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Growth factors induce differential phosphorylation profiles of the Hrs–STAM
complex: a common node in signalling networks with signal-specific
properties
Paula E. ROW, Michael J. CLAGUE and Sylvie URBE´1
Physiological Laboratory, University of Liverpool, Crown St., Liverpool L69 3BX, U.K.
Hrs (hepatocyte growth factor-regulated tyrosine kinase substrate)
and STAM (signal-transducing adaptor molecule) form a hetero-
dimeric complex that associates with endosomal membranes and
is tyrosine-phosphorylated in response to a variety of growth
factors including EGF (epidermal growth factor), HGF (hepato-
cyte growth factor) and PDGF (platelet-derived growth factor).
Phosphorylation of the Hrs–STAM complex requires receptor
endocytosis. We show that an intact UIM (ubiquitin interaction
motif) within Hrs is a conserved requirement for Hrs phosphoryl-
ation downstream of both EGF and HGF stimulations. Consistent
with this, expression of a dominant-negative form of the E3 ubi-
quitin ligase, c-Cbl, inhibits EGF- and HGF-dependent Hrs phos-
phorylation. Despite this conservation, kinase inhibitor pro-
files using PP1 (4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo
[3,4-d]pyrimidine) and SU6656 indicate that distinct non-receptor
tyrosine kinases couple EGF, HGF and PDGF stimulation with
the tyrosine phosphorylation of the Hrs–STAM complex. Cru-
cially, analysis with phospho-specific antibodies indicates that
these kinases generate a signal-specific, combinatorial phosphory-
lation profile of the Hrs–STAM complex, with the potential of di-
versifying tyrosine kinase receptor signalling through a common
element.
Key words: growth factor, Hrs, phosphorylation, signal trans-
duction, signal-transducing adaptor molecule (STAM), ubiquitin
interaction motif (UIM).
INTRODUCTION
Activated tyrosine kinase receptors are removed from the cell
surface by clathrin-coated vesicle-mediated endocytosis and
delivered to a tubulovesicular sorting endosome [1]. Tyrosine
kinase receptors such as EGFR [EGF (epidermal growth factor)
receptor] and c-Met are ubiquitinated after stimulation through
recruitment of the E3 ligase, c-Cbl [2,3]. Ubiquitinated receptors
are recognized by a UIM (ubiquitin interaction motif)-containing
protein, Hrs [HGF (hepatocyte growth factor)-regulated tyrosine
kinase substrate], which is highly enriched in regions of the
endosome that are characterized by a specialized clathrin coat
[4,5]. Hrs is believed to couple the concentration of ubiquitinated
receptors with recruitment of an extensive machinery for MVB
(multivesicular body) formation [6]. This machinery comprises
a set of multiprotein complexes [ESCRT (endosomal-associated
complex required for transport) I, II and III], which participate in
a vectorial chain of recruitment and association at the prevacuolar
membrane necessary for MVB formation [7]. Once incorporated
into these luminal vesicles, receptor signalling is terminated and
the receptors are usually destined for lysosomal degradation.
Hrs was originally identified as a prominent target for tyrosine
phosphorylation after HGF stimulation of the tyrosine kinase
receptor c-Met [8]. Activation of other tyrosine kinase receptors
and stimulation with cytokines such as IL-2 (interleukin 2) and
GM-CSF (granulocyte/macrophage colony-stimulating factor)
also result in phosphorylation of Hrs [9]. Both HGF- and EGF-
dependent phosphorylation of Hrs requires coincident localization
of activated receptor and Hrs at early endosomes, to which Hrs
is targeted by interaction of its FYVE domain with PtdIns3P
[10,11]. The channelling of such diverse signalling pathways into
Hrs phosphorylation has suggested that it may play a conserved
role in receptor sorting and/or signalling pathways. Enrichment of
phospho-Hrs in the cytosol, despite the fact that phosphorylation
occurs at the endosome led to the suggestion that this translocation
may reflect a phosphorylation-dependent release mechanism that
is important for the progression of receptor incorporation into
MVBs [11,12]. However, results of a recent study have shown that
Hrs contributes to sorting of a seven-transmembrane G-protein
receptor in the absence of any detectable phosphorylation [13]. A
role for Hrs phosphorylation in signalling relays is an alternative
possibility. Hrs is constitutively associated with STAM (signal-
transducing adaptor molecule) [9], which undergoes tyrosine
phosphorylation in parallel with Hrs [11]. An SH3 (Src-homology
3) deletion mutant of STAM confers a dominant-negative effect
on DNA synthesis mediated by IL-2 and GM-CSF [14].
We have previously confirmed the major EGF-dependent phos-
phorylation site on Hrs as Tyr334 [12], whilst systematic mass
spectroscopic profiling of the EGF-signalling pathway has
identified Tyr198 as a prominent phosphorylation site in STAM
[15]. In the present study, we have compared the phosphorylation
of the Hrs–STAM complex downstream of the acute activation of
three tyrosine kinase receptors, which are all known to enter the
lysosomal degradation pathway: EGFR, PDGFR [PDGF (platelet-
derived growth factor) receptor] and c-Met. These three receptors
activate many common signalling pathways, such as mitogen-acti-
vated protein kinase and PKB/Akt (where PKB stands for protein
kinase B) pathways, yet have distinct physiological effects on
Abbreviations used: EGF, epidermal growth factor; EGFR, EGF receptor; GFP, green fluorescent protein; GM-CSF, granulocyte/macrophage colony-
stimulating factor; HA, haemagglutinin; HGF, hepatocyte growth factor; Hrs, hepatocyte growth factor-regulated tyrosine kinase substrate; IL-2, interleukin 2;
MVB, multivesicular body; NP40, Nonidet P40; PDGF, platelet-derived growth factor; PDGFR, PDGF receptor; PKB, protein kinase B; PP1, 4-amino-5-(4-
methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine; STAM, signal-transducing adaptor molecule; UIM, ubiquitin interaction motif.
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cells. For example, in addition to cell growth, c-Met activation
uniquely promotes motility and tubule formation of epithelial
cells [16]. Our results demonstrate distinct combinations of
phosphorylation sites associated with each stimulus, suggesting
that Hrs–STAM phosphorylation may be one coding mechanism
through which the respective signalling outputs are diversified.
We have also examined the mechanism of Hrs–STAM phos-
phorylation. Previous work has shown a requirement for a func-
tional endocytic pathway in order to achieve Hrs phosphorylation
downstream of HGF and EGF stimulation [10,11]. Furthermore,
an intact UIM domain within Hrs is required for EGF-dependent
phosphorylation of Hrs [12]. In the present study, we have ex-
tended this analysis of the role of the UIM domain to HGF stimu-
lation and in addition show that Cbl E3 ubiquitin ligase activity
is required for growth factor-mediated Hrs phosphorylation, sug-
gesting a common ubiquitin-dependent mechanism linking activ-
ated receptors to Hrs phosphorylation.
It has previously been suggested that a downstream kinase, such
as c-Src, rather than EGFR kinase itself could be responsible
for Hrs phosphorylation [17]. We have profiled the diverse
phosphorylation events associated with distinct stimuli against
the Src-specific tyrosine kinase inhibitor SU6656 [18] and the
less-specific tyrosine kinase inhibitor PP1 (4-amino-5-(4-methyl-
phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine) [19]. We show that
the differing phosphorylation outputs are due to the actions of
distinct kinase activities, demonstrating that c-Src cannot be a
universal intermediary between tyrosine kinase activation and
Hrs–STAM phosphorylation.
The present study is one of the first detailed studies of a
common node in phosphorylation-dependent signalling networks
elicited by multiple growth factor stimulation for which the
phosphorylation status of the substrate has been shown to differ.
Our results suggest a cautionary approach in extrapolating the
results of phospho-proteomic studies that pertain to individual
growth factors.
EXPERIMENTAL
Cell culture, plasmids and transfections
HeLa cells and HER14 cells (NIH3T3 fibroblasts stably trans-
fected with the human EGFR [20]) were cultured in 5% CO2 in
Dulbecco’s modified Eagle’s medium supplemented with 10%
(v/v) foetal calf serum and 1% non-essential amino acids. All
tissue culture reagents were purchased from Invitrogen Life
Technologies (Paisley, U.K.).
Plasmids comprising the open reading frame of Hrs and Leu269/
S270A (Ser270→Ala) Hrs cloned into pEGFPC1 have been de-
scribed previously [12]. A construct encoding a constitutively
active Src (Y527F Src) was a gift from Dr S. Courtneidge (Van
Andel Research Institute, Grand Rapids, MI, U.S.A.). Constructs
encoding wild-type Cbl and 70Z-Cbl were gifts from Dr
Y. Yarden (Weizmann Institute, Rehovet, Israel). HeLa cells were
transfected with FuGENE 6 (Roche Diagnostics, Lewes, East
Sussex, U.K.) or GeneJuice transfection reagent (Novagen, Merck
Biosciences, Nottingham, U.K.) according to the manufacturer’s
instructions.
Antibodies and other reagents
Anti-Hrs and anti-phospho-Tyr334-Hrs (PY334) rabbit polyclonal
antibodies have been described previously [12]. A rabbit poly-
clonal anti-Stam antibody was generated against the N-terminal
peptide MPLFTANPFEQDVEC (Abcam, Cambridge, U.K.).
Anti-phospho-Tyr198-Stam (PY198) antibody was generated
against the peptide QHTETKSLpYPSSE (CovalAb, Cambridge,
U.K.). Affinity-purified anti-GFP (where GFP stands for green
fluorescent protein) sheep polyclonal antibody [21] was a gift
from Dr F. Barr (Max Planck Institute, Martinsried, Germany).
Other antibodies were obtained commercially as follows: anti-
HA (where HA stands for haemagglutinin) rabbit polyclonal
and mouse monoclonal antibodies (Covance Research Products,
Princeton, NJ, U.S.A.), mouse monoclonal anti-EGFR R1, goat
polyclonal anti-EGFR 1005, and anti-PDGFRβ rabbit polyclonal
antibody (Santa Cruz Biotechnology, CA, U.S.A.), anti-phospho-
tyrosine monoclonal antibody PY20 (Transduction Laboratories,
Lexington, KY, U.S.A.), Alexa Fluor 488- and 594-coupled
secondary antibodies (Molecular Probes), horseradish peroxi-
dase-coupled secondary antibodies and the mouse monoclonal
anti-ubiquitin antibody P4G7 (Sigma). Protein A–agarose and
Protein G–agarose were obtained from Sigma, purified mouse
EGF was from Dr J. Smith (Liverpool, U.K.), purified human HGF
was from Genentech (San Francisco, CA, U.S.A.) and PDGF-
BB was from Calbiochem, Merck Biosciences (Nottingham,
U.K.). PP1 was obtained from Alexis (San Diego, CA, U.S.A.)
and SU6656 was from SUGEN (San Francisco, U.S.A.).
Stimulation of cells with growth factors
Cells were starved for 16 h in serum-free medium, preincubated
with kinase inhibitors where indicated (PP1 at 2.5 µM for 15 min,
SU6656 at 2 µM for 1 h) and stimulated with EGF (100 ng/ml),
HGF (250 ng/ml) and PDGF (30 ng/ml) for 8 min at 37 ◦C. The
cells were washed twice with ice-cold PBS and lysed for 10 min
on ice in either NP40 (Nonidet P40) lysis buffer (25 mM Tris/
HCl, pH 7.5, 100 mM NaCl, 0.5%, w/v, NP40 and 50 mM NaF)
or NP40-RIPA buffer (10 mM Tris/HCl, pH 7.5, 100 mM NaCl,
1%, w/v, NP40, 0.1%, w/v, SDS, 1%, w/v, sodium deoxycholate
and 50 mM NaF), supplemented in each case with mammalian
protease inhibitor cocktail and phosphatase inhibitor cocktail II
(Sigma). The lysates were precleared by centrifugation and im-
munoprecipitations were set up with antibodies and Protein
A–agarose or Protein G–agarose for 4 h at 4 ◦C. For immuno-
precipitation of ubiquitinated EGFR and PDGFR, 10 mM N-
ethylmaleimide was added to the lysis buffer to inhibit protein
deubiquitination. Immunoprecipitated proteins were analysed as
described in [12]. Blots were routinely stripped and reprobed to
ensure that equal amounts of protein had been loaded.
Immunofluorescence
Cells were washed twice with PBS and fixed either with methanol
or with 3% (w/v) paraformaldehyde. For methanol fixation, cells
were incubated with methanol at −20 ◦C for 5 min followed by
drying for 8 min and rehydration in PBS. Alternatively, cells were
processed as described in [12]. Cells were viewed using a Bio-
Rad LaserSharp confocal microscope. Single confocal sections
were taken at 260 nm steps and analysed with the accompanying
software.
RESULTS
A common requirement for a UIM domain in Hrs for EGF-
and HGF-mediated tyrosine phosphorylation
We have previously shown that Hrs phosphorylation in re-
sponse to EGF is dependent on an intact UIM domain, which
is proposed to mediate interaction with the ubiquitinated EGFR
[12]. We now show that this requirement is conserved for phos-
phorylation of Hrs in response to HGF stimulation of the receptor
c© 2005 Biochemical Society
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Figure 1 A common requirement for a UIM in Hrs for EGF- and HGF-
mediated Hrs tyrosine phosphorylation
(a) HeLa cells were transfected with GFP–Hrs or the Hrs–UIMmutant GFP–LSAA and stimulated
22 h post-transfection with EGF (100 ng/ml) or HGF (250 ng/ml) after a 16 h starvation
period. GFP–Hrs was immunoprecipitated and tyrosine phosphorylation was assessed by
immunoblotting with PY20 antibody (P-Tyr). Lysates prepared as described above were analysed
by immunoblotting with anti-GFP antibody. (b) An oncogenic Cbl mutant interferes with Hrs
phosphorylation. HeLa cells were transfected with GFP–Hrs and pCDNA3.1 control vector (V),
HA-tagged c-Cbl or 70Z-Cbl and then stimulated 22 h post-transfection with EGF or HGF
after a 16 h starvation period. GFP–Hrs was immunoprecipitated and samples were analysed
by immunoblotting with P-Tyr and reprobed with anti-Hrs antibody. Lysate samples prepared
as described above were analysed by immunoblotting with anti-Hrs or anti-HA antibody to
assess relative expression levels (note that the band indicated by ∗ corresponds to endo-
genous Hrs).
tyrosine kinase c-Met (Figure 1a). GFP–Hrs or a mutant, con-
taining two amino acid changes within the UIM domain (LSAA),
which ablate ubiquitin binding activity [12], were expressed in
HeLa cells. After stimulation of cells with EGF or HGF, the
wild-type and mutant Hrs were immunoprecipitated and probed
with an anti-phosphotyrosine antibody (PY20). Wild-type Hrs
was phosphorylated in response to both growth factors, whereas
this response was greatly reduced for the UIM domain mutant.
An oncogenic Cbl mutant interferes with Hrs phosphorylation
We have previously shown that Hrs phosphorylation in response
to EGF and HGF is dependent on clathrin-mediated endocytosis
and PtdIns3P-dependent localization of Hrs to endosomes [10,11].
Hrs has been proposed to recruit ubiquitinated receptors to the
endosomal clathrin coat before their inclusion into the internal
vesicles of the MVB [5,6,22]. If this interaction is necessary
for Hrs phosphorylation, as suggested by the requirement for an
intact UIM domain, then interference with receptor ubiquitination
should also oppose Hrs phosphorylation.
In common with several tyrosine kinases, EGFR and Met
are both ubiquitinated by the E3-RING ligase, Cbl [2,3,23,24].
In order to interfere with receptor ubiquitination, we have co-
expressed c-Cbl or a RING-deletion mutant 70Z-Cbl, which has
been shown to lack E3-ligase activity [2] together with GFP–Hrs.
Expression of 70Z-Cbl, but not c-Cbl, strongly suppressed both
HGF- and EGF-mediated phosphorylation of Hrs (Figure 1b).
Whilst the 70Z-Cbl mutant has previously been reported to reduce
the rate of EGFR internalization [25], we clearly observe a high
degree of coincident localization of GFP–Hrs and EGFR in 70Z-
Cbl co-transfected cells after 8 min of EGF stimulation (Figure 2),
and hence the moderate suppression of EGFR entry into Hrs-
containing endosomes by 70Z-Cbl on its own is unlikely to cause
the striking inhibition of GFP–Hrs phosphorylation observed in
Figure 1(b).
Src-kinase inhibitor profiles suggest distinct mechanisms of Hrs
and STAM phosphorylation
Hrs and STAM are both phosphorylated in response to a variety
of growth signals including both receptor tyrosine kinase ligands
and cytokines. A common denominator in these diverse signal-
ling cascades is the activation of members of the Src-kinase
family. A previous study has shown that Hrs can be phosphoryl-
ated by c-Src in vitro but is, nevertheless, phosphorylated
in EGFR-transfected Src-Yes-Fyn-knockout cells [17]. We
have previously characterized a phospho-specific Hrs antibody
recognizing phospho-Tyr334, which is generated after EGF stimul-
ation [12]. Whereas Hrs is clearly phosphorylated in non-
stimulated cells transfected with constitutively active Src, as
judged by blotting with an anti-phosphotyrosine antibody (PY20),
Tyr334 is not a target for Src (Figure 3a). We have also generated
a phospho-specific antibody against phospho-Tyr198 in STAM
that has been identified by mass spectroscopic analysis of EGF-
evoked phosphorylation of proteins [15]. Parallel analysis of
the phosphorylation state of STAM in cells transfected with
constitutively active Src (Y527F) versus EGF-stimulated cells
shows that Tyr198 can be phosphorylated by Src in addition to
other uncharacterized tyrosine residues (Figure 3b).
To analyse further the involvement of Src kinases in the phos-
phorylation of the Hrs–STAM complex in response to various
signals, we made use of two distinct kinase inhibitors with
high and moderate specificities for Src-kinase family members,
SU6656 and PP1 [18,19]. First, we compared EGF- and HGF-
mediated phosphorylation in HeLa cells and found that EGF,
but not HGF-dependent phosphorylation of both Hrs and STAM,
is sensitive to PP1, whereas neither was inhibited by SU6656
(Figure 4a). Secondly, we made use of HER14 cells, which are
NIH3T3 cells that are stably transfected with EGFR [20], thus
enabling us to compare directly EGF- with PDGF-mediated phos-
phorylation of Hrs and STAM, since PDGFR is not expressed
in HeLa cells. In contrast with both EGF- and HGF-mediated
phosphorylation of Hrs and STAM, we found that PDGF-
mediated phosphorylation is inhibited by both Src-kinase inhibi-
tors PP1 and SU6656, whereas the EGF-dependent phosphoryl-
ation showed an inhibitor profile identical with that observed
in HeLa cells (Figure 4b and Table 1). As reported previously
[18,19], both inhibitors generate discernible differences in the
total cellular phospho-tyrosine profile (Figures 4c and 4d).
Importantly, at the concentrations we have used, neither inhibitor
significantly affects EGFR or PDGFR phosphorylation and ubi-
quitination (Figure 5), nor do they inhibit endocytosis of EGFR
to an Hrs-positive endosomal compartment (Figure 6).
Generation of distinct combinatorial tyrosine phosphorylation
patterns in response to distinct signal inputs
Since Hrs–STAM phosphorylation displays different inhibitor
profiles according to stimulus, we next asked whether the phos-
phorylation sites are conserved. To address this question, we
made use of our phospho-specific Hrs and STAM antibodies (see
above) and compared the total phospho-tyrosine signals in Hrs
immunoprecipitates with specific phospho-Tyr334 and -Tyr198 sig-
nals in response to either EGF or HGF stimulation in HeLa cells.
Whereas phosphorylation of STAM on Tyr198 can be observed
c© 2005 Biochemical Society
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Figure 2 Co-localization of EGFR and GFP–Hrs in cells expressing c-Cbl and 70Z-Cbl mutant
HeLa cells were seeded on to coverslips and transfected with GFP–Hrs and pCDNA3 (control), HA-tagged c-Cbl or 70Z-Cbl and then stimulated for 8 min with 100 ng/ml EGF 22 h post-transfection
after a 16 h starvation period. The cells were fixed with 3% paraformaldehyde, permeabilized with Triton X-100 and stained with anti-EGFR (EGFR shown in red) followed by a secondary antibody
coupled with Alexa Fluor 594. All panels show a single confocal section. Scale bars, 20µm.
Figure 3 Comparison of tyrosine phosphorylation of Hrs and STAM in
response to EGF and constitutively active Src
HeLa cells were transfected with constitutively active Y527F-Src (src) or pCDNA3.1 (–), starved
for 16 h in serum-free medium and then stimulated 22 h post-transfection for 8 min with EGF
(100 ng/ml). (a) Lysates were subjected to immunoprecipitation with anti-Hrs antibody and
analysed by immunoblotting (IB) with either PY20 antibody (P-Tyr) or anti-PY334-Hrs antibody.
The blots were stripped and reprobed with anti-Hrs antibody. (b) Lysates were subjected to
immunoprecipitation with anti-STAM antibody and analysed by immunoblotting with either
P-Tyr or anti-PY198-STAM antibody. The blots were stripped and reprobed with anti-STAM
antibody.
in both EGF- and HGF-stimulated cells, Hrs is clearly phos-
phorylated on alternative tyrosine residues after HGF stimulation
(Figures 7a and 7b). Turning to HER14 cells in order to analyse
PDGF-mediated phosphorylation, PDGF, in common with EGF,
elicits phosphorylation of Tyr334 in Hrs, but, in contrast with
EGF, does not elicit a substantial signal for phospho-Tyr198 in
STAM (Figures 7c and 7d). Thus each growth factor stimulus
generates a distinct phosphorylation profile on the Hrs–STAM
complex as summarized in Table 2.
DISCUSSION
Tyrosine kinase receptors channel signals through shared path-
ways but generate distinct biological outputs. This may be due to
cell-type restriction of responses or to the specific combination
of signals produced by receptor activation [26,27]. It has recently
become well appreciated that receptor trafficking dynamics can
influence the signal output [28,29]. Phosphorylation of the
endosome-restricted substrate, Hrs, is a clear-cut example of this
principle. Our previous results have suggested that coincident
endosomal localization of the receptor (EGFR or Met) and Hrs,
as well as correct sorting of that receptor within the endosome,
are a prerequisite for Hrs phosphorylation [10,11]. Hrs is a key
player in the sorting mechanism through recognition of ubiquit-
inated receptors by its UIM domain. Overexpression of Hrs
c© 2005 Biochemical Society
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Figure 4 Differential effect of Src-kinase inhibitors on EGF-, HGF- and PDGF-stimulated phosphorylation of Hrs and STAM
(a) HeLa cells or (b) HER14 cells were serum-starved for 16 h, preincubated either with 2 µM SU6656 (SU) or vehicle for 1 h or with 2.5µM PP1 for 15 min, and stimulated with EGF (100 ng/ml),
HGF (250 ng/ml) or PDGF (30 ng/ml) for 8 min at 37◦C or left unstimulated. Cell lysates were subjected to immunoprecipitation with anti-Hrs antibody and tyrosine phosphorylation was assessed
by immunoblotting with PY20 antibody (P-Tyr, top panels). Note that the upper band corresponds to phospho-Hrs and the lower band to co-precipitated phospho-STAM. The blots were stripped and
reprobed with anti-Hrs antibody (bottom panels). (c, d) Lysates, prepared from cells treated as in (a, b), were directly analysed by immunoblotting with P-Tyr antibody and they displayed altered
tyrosine phosphorylation profiles (arrows).
Table 1 Distinct Src-kinase inhibitor profiles for Hrs–STAMphosphorylation
in response to different growth factors
Phosphorylation of Hrs–STAM inhibited?
Growth factor PP1 SU6656
EGF Yes No
HGF No No
PDGF Yes Yes
has a dominant-negative effect on EGFR sorting to MVBs by
inhibiting internal vesicle formation [12]. This inhibitory effect
of Hrs overexpression does not require phosphorylation of Tyr334
and is mediated by the UIM domain, which effectively couples
receptor sorting to internal vesicle formation. Results of the pre-
sent study suggest that Hrs phosphorylation may be contingent
upon direct interaction between ubiquitinated receptors and Hrs,
since disruption of the UIM domain inhibits phosphorylation
downstream of either HGF or EGF.
The corollary to UIM domain mutation experiments is the
inhibition of receptor ubiquitination, which can be effected by
expression of dominant-negative mutants of the E3 ligase, c-Cbl
[23]. Our finding that the 70Z-mutated form of c-Cbl inhibits
Hrs phosphorylation is consistent with the above interpretation.
However, we should acknowledge the caveat that there is some
reduction in receptor endocytosis after the expression of this
mutant [25], although this does not appear to be as acute.
Figure 5 Phosphorylation and ubiquitination of EGFR and PDGFRs in the
presence of Src-kinase inhibitors
HER14 cells were serum-starved for 16 h, preincubated either with 2µM SU6656 or vehicle
for 1 h or with 2.5µM PP1 for 15 min and stimulated with (a, c) 100 ng/ml EGF or (b, d)
30 ng/ml PDGF, for 8 min at 37◦C. Cell lysates were subjected to immunoprecipitation with (a,
c) anti-EGFR or (b, d) anti-PDGFR antibody. Phosphorylation and ubiquitination were assessed
with PY20 antibody (P-Tyr) and anti-ubiquitin antibody respectively. The blots were re-
probed with anti-EGFR or anti-PDGFR antibody (bottom panels).
If a requirement for direct receptor interaction is conserved
between HGF- and EGF-dependent phosphorylation of Hrs, the
simplest model is that the receptor tyrosine kinase activity is di-
rectly responsible for Hrs phosphorylation. Although this may yet
c© 2005 Biochemical Society
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Figure 6 Co-localization of internalized EGFR with Hrs in the presence of Src-kinase inhibitors
HeLa cells were seeded on to coverslips, serum-starved for 16 h, preincubated either with 2µM SU6656 or vehicle for 1 h or with 2.5µM PP1 for 15 min, and stimulated with 100 ng/ml EGF for
8 min at 37◦C. The cells were fixed with methanol and stained with anti-EGFR (EGFR, shown in green) and anti-Hrs antibody (Hrs, shown in red) followed by secondary antibodies coupled with
Alexa Fluor 488 and Alexa Fluor 594 respectively. All panels show a single confocal section. Scale bars, 20µm.
be true in the specific case of Met receptor, it cannot be true for
EGFR or PDGFR. This is shown by our finding that pharma-
cological treatment with particular tyrosine kinase inhibitors can
diminish growth factor-dependent Hrs phosphorylation without
affecting the receptor tyrosine kinase activity (Figures 4 and
5). Our results also show that there is no universal tyrosine
kinase adapter between tyrosine kinase receptors and Hrs. In fact,
the inhibitor profile indicates that distinct kinases mediate Hrs
phosphorylation downstream of all the three specific signals. For
PDGF stimulation, the relevant kinase could conceivably be an
Src-family member since it is inhibited by both PP1 and SU6656
at concentrations for which each has optimal specificity (but see
below). PP1 has previously been reported to inhibit PDGF rece-
ptor tyrosine phosphorylation [30]. We do not observe a significant
effect of PP1 on PDGFR phosphorylation in our cells with the
short incubation times that we used. The fact that the more specific
inhibitor SU6656 equally inhibits Hrs phosphorylation makes
it unlikely that this inhibition is due to an upstream effect on
PDGFR. c-Src cannot mediate either HGF- or EGF-dependent Hrs
phosphorylation since this is either insensitive to both inhibitors
(HGF) or the more specific SU6656 inhibitor (EGF). Note that, at
the concentrations of inhibitors we have used, we do not see any
defect in receptor trafficking or ubiquitination. This is in contrast
with previous studies, which have used an order of magnitude
higher concentrations of PP1, which is capable of inhibiting EGFR
ubiquitination [31].
Although rigorous comparison of stimulus-dependent phospho-
proteomes is in its infancy, one might expect that highly conserved
elements would also show conservation of phosphorylation
profiles. This is certainly true in some cases where phosphoryl-
ation provides a very specific switch, which governs enzyme
activity (e.g. PKB). Alternatively, phosphorylation could also be
used as a means of diversifying signals by providing distinct
recruitment sites for downstream signalling elements to shared
adapter proteins.
We have shown that stimulus-specific tyrosine kinases mediate
Hrs phosphorylation. Would this necessarily lead to an altered
phosphorylation profile of the Hrs–STAM complex? For EGF
stimulation, we and others have characterized Tyr334 on Hrs and
Tyr198 on STAM as principal sites for phosphorylation [12,15].
We have raised phospho-specific antibodies that specifically
recognize these modifications. Application of these antibodies to
the examination of stimulus-dependent phosphorylation revealed
that each stimulus produces a unique combination of phospho-
tyrosines on the Hrs–STAM complex, although individual
modifications may be shared. For example, both EGF stimulation
and HGF stimulation result in STAM phosphorylation at Tyr198,
whereas HGF promotes the phosphorylation of an as yet
unidentified tyrosine distinct from Tyr334 on Hrs (summarized in
Table 2). Tyr334 is, however, phosphorylated in response to PDGF.
Although inhibitor studies were suggestive that c-Src might be the
relevant kinase downstream of PDGF, we do not find any Tyr334
phosphorylation when we express a constitutively active form of
Src, although it efficiently phosphorylates Hrs at (an) alternative
site(s). This suggests that the relevant kinase may be an alter-
native member of the Src family.
Although we have not directly addressed the specific cellular
role of Hrs–STAM phosphorylation in the present study, our
c© 2005 Biochemical Society
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Figure 7 Generation of distinct combinatorial tyrosine phosphorylation patterns in response to distinct signal inputs
(a, b) HeLa cells were starved for 16 h in serum-free medium and stimulated for 8 min with EGF (100 ng/ml) or HGF (250 ng/ml). (a) Lysates were subjected to immunoprecipitation with anti-Hrs
antibody and tyrosine phosphorylation was assessed by immunoblotting with (P-Tyr; top panels). Blots were stripped and reprobed with anti-Hrs or anti-Stam antibody (bottom panels). (b) Lysates
were analysed by immunoblotting with anti-PY334-Hrs or anti-PY198-STAM antibody and blots were stripped and reprobed as in (a). (c, d) HER14 cells were serum-starved for 16 h and either
not stimulated or stimulated for 8 min with EGF (100 ng/ml) or PDGF (30 ng/ml). (c) Lysates were subjected to immunoprecipitation with anti-STAM antibody and immunoblotted with P-Tyr (top
panels). Blots were reprobed with anti-Hrs or anti-STAM antibody (bottom panels). (d) Lysates were subjected to immunoprecipitation with anti-STAM antibody and subjected to immunoblotting
with anti-PY334-Hrs or anti-PY198-STAM antibody. Blots were stripped and reprobed as in (a).
Table 2 Differential tyrosine phosphorylation of the Hrs–STAM complex in
response to different growth factors
Phosphorylation?
Protein phosphorylated Residue EGF HGF PDGF
Hrs Tyr334 Yes No Yes
STAM Tyr198 Yes Yes No
results clearly show that it cannot be a general requirement for
Hrs-dependent receptor sorting. We favour the idea that it provides
a way to couple the sorting of specific receptors with other down-
stream functions that the complex may engage in. The fact that
a significant pool of the phosphorylated form can be found in
the cytosol [12], as well as the wealth of interactions detected
by two-hybrid screening in various model studies, suggests that
Hrs–STAM function is not confined to receptor sorting at the
endosome.
It is of great interest to understand how distinct biological out-
comes are determined by the activation of specific tyrosine kinase
receptors, despite the apparent engagement of common signalling
pathways. The differential phosphorylation profile of the Hrs–
STAM complex, described in this case study, provides a potential
novel mechanism for diversifying signals through a common
node in tyrosine kinase receptor signalling pathways. It will be a
challenge for future phospho-proteomic studies to determine how
widely this principal has been adopted.
We thank theWellcome Trust for support and S. Courtneidge (Van Andel Research Institute,
Grand Rapids, MI, U.S.A.) for helpful discussions.
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